U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040306) titled 'A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China' on June 03.
Brief Summary: This study was a prospective follow-up study of newly diagnosed and relapsed Graves' disease patients in the Endocrinology Clinic of the First Affiliated Hospital of China Medical University. The following aspects will be studied: 1. Through the prospective follow-up study of GD patients, we will get the relapse rate and remission rate of GD patients treated with drugs, explore the risk factors of GD patients relapsing after drug treatment, and make GD relapse risk prediction software; 2. To compare the effects of high dose a...